Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal Cancer
NCT02937519 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2018-06-06
Summary
1. Observe and compare the chrono-chemotherapy IMRT and conventional chemotherapy and intensity modulated radiotherapy term efficacy of the treatment of locally advanced nasopharyngeal carcinoma.
2. Evaluation chrono-chemotherapy IMRT and conventional chemotherapy and intensity modulated radiotherapy in locally advanced nasopharyngeal carcinoma safety and tolerability.
3)observing the adverse reaction and effects of two groups,expected chrono-chemotherapy group can achieve lower toxicity, improve the curative effect, for the treatment of nasopharyngeal carcinoma provides a more reasonable way.
Conditions
- Esophageal Neoplasms
Interventions
- DEVICE
-
Chrono-chemotherapy pump:Melodie
- DEVICE
-
Routine intravenous drip
- DRUG
-
induction Chrono-chemotherapy
- DRUG
-
induction Routine-chemotherapy
- DRUG
-
cisplatin chrono-chemotherapy
- DRUG
-
cisplatin routine-chemotherapy
- RADIATION
-
intensity-modulated radiation therapy
Sponsors & Collaborators
-
The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University
collaborator UNKNOWN -
Sun Yat-sen University
collaborator OTHER -
Guiyang Medical University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2018-06-30
- Completion
- 2018-06-30
Countries
- China
Study Locations
More Related Trials
-
Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era
NCT02633202 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma
NCT00817258 ·Status: UNKNOWN ·Phase: PHASE2
-
Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
NCT04136886 ·Status: RECRUITING ·Phase: PHASE3
-
Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma
NCT00778908 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma
NCT06688175 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma
NCT02610010 ·Status: RECRUITING ·Phase: PHASE3
-
A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma
NCT02512315 ·Status: UNKNOWN ·Phase: PHASE3
-
Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy
NCT02289807 ·Status: WITHDRAWN ·Phase: NA
-
Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma
NCT02871518 ·Status: UNKNOWN ·Phase: PHASE2
-
A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients
NCT04061278 ·Status: UNKNOWN ·Phase: PHASE3
-
Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC
NCT03366415 ·Status: UNKNOWN ·Phase: PHASE3
-
Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma
NCT03668730 ·Status: UNKNOWN ·Phase: PHASE2
-
Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
NCT07328841 ·Status: RECRUITING ·Phase: PHASE3
-
The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT
NCT01817023 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma
NCT05979961 ·Status: RECRUITING ·Phase: PHASE3
-
Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT05527470 ·Status: RECRUITING ·Phase: PHASE3
-
Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03020329 ·Status: UNKNOWN ·Phase: PHASE2
-
Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03389295 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma
NCT03015727 ·Status: UNKNOWN ·Phase: PHASE3
-
Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT01872962 ·Status: UNKNOWN ·Phase: PHASE3
-
Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
NCT06092957 ·Status: RECRUITING ·Phase: PHASE3
-
Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin
NCT02562599 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)
NCT00817583 ·Status: UNKNOWN ·Phase: PHASE2
-
Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT01245959 ·Status: UNKNOWN ·Phase: PHASE3
-
Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma
NCT03908372 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3